Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRESY | MMM |
|---|---|---|
| Price | $11.61 | $162.29 |
| Change today | ▼ 0.17% | ▲ 0.10% |
| Market cap | $823.44M | $83.69B |
| Return, 3 months | +11.5% | +4.9% |
| Return, year to date | -8.1% | +2.8% |
| Return, 1 year | +33.0% | +5.9% |
| P/E (TTM) | 6.5 | 28.8 |
| P/B | 0.9 | 28.4 |
| P/E percentile vs own 5y | 70th | 88th |
| Dividend yield | 5.28% | 1.86% |
| Revenue growth (YoY, latest qtr) | +8.3% | +2.5% |
| Net profit growth (YoY) | -36.6% | +29.4% |
| Gross margin | 39.0% | 39.4% |
| Operating margin | 17.0% | 20.4% |
| Net margin | 12.9% | 11.9% |
| Return on equity | 14.6% | 82.8% |
| Analyst target vs. price | – | +16.5% |
| Analyst buy share | – | 42% |
| RSI (14) | 46 | 39 |
| 30-day volatility | 47.0% | 19.7% |
| Max drawdown, 1 year | -26.5% | -18.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
